| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 197.696 | 83 |
| GSM780708 | Untreated after 4 days (C2_1) | 544.821 | 92 |
| GSM780709 | Untreated after 4 days (C3_1) | 553.641 | 92 |
| GSM780719 | Untreated after 4 days (C1_2) | 208.418 | 84 |
| GSM780720 | Untreated after 4 days (C2_2) | 574.399 | 92 |
| GSM780721 | Untreated after 4 days (C3_2) | 598.531 | 93 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 1075.05 | 96 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 570.335 | 92 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 648.859 | 93 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 1033.48 | 96 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 595.57 | 93 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 740.376 | 94 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 310.223 | 88 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 796.837 | 94 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 446.03 | 91 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 333.768 | 88 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 811.247 | 95 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 428.295 | 90 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 1106.59 | 96 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 838.004 | 95 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 768.225 | 94 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 1021.93 | 96 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 847.756 | 95 |